Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,015,675 | 818,900 | 476,632 | 437,446 | 423,220 |
| Marketable Securities | 489,998 | 561,472 | 381,764 | 316,361 | 297,572 |
| Receivables | 411,712 | 381,215 | 396,384 | 377,404 | 402,970 |
| Inventories | 700,847 | 743,852 | 705,652 | 680,275 | 609,049 |
| Other current assets | 120,747 | 142,127 | 155,817 | 130,657 | 126,548 |
| TOTAL | $2,738,979 | $2,647,566 | $2,116,249 | $1,942,143 | $1,859,359 |
| Non-Current Assets | |||||
| PPE Net | 1,015,062 | 1,010,917 | 1,009,972 | 1,010,868 | 969,300 |
| Investments And Advances | 265,122 | 323,058 | 290,796 | 411,978 | 431,804 |
| Intangibles | 623,371 | 629,580 | 639,916 | 653,619 | 659,888 |
| Other Non-Current Assets | 1,515,556 | 690,989 | 665,908 | 671,431 | 637,777 |
| TOTAL | $3,419,111 | $2,654,544 | $2,606,592 | $2,747,896 | $2,698,769 |
| Total Assets | $6,158,090 | $5,302,110 | $4,722,841 | $4,690,039 | $4,558,128 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 374,290 | 370,100 | 365,964 | 361,882 | N/A |
| Accounts payable and accrued liabilities | 480,403 | 443,202 | 454,506 | 570,621 | 493,745 |
| TOTAL | $854,693 | $813,302 | $820,470 | $932,503 | $493,745 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,249,504 | 1,252,129 | 662,409 | 635,155 | 989,978 |
| TOTAL | $1,249,504 | $1,252,129 | $662,409 | $635,155 | $989,978 |
| Total Liabilities | $2,104,197 | $2,065,431 | $1,482,879 | $1,567,658 | $1,483,723 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 181,530 | 181,350 | 180,837 | 179,926 | 179,625 |
| Common Shares | 181 | 181 | 181 | 180 | 180 |
| Retained earnings | -883,708 | -1,668,511 | -1,639,328 | -1,720,709 | -1,735,733 |
| Other shareholders' equity | -371 | 19,372 | 24,295 | 10,203 | 27,042 |
| TOTAL | $4,053,893 | $3,236,679 | $3,239,962 | $3,122,381 | $3,074,405 |
| Total Liabilities And Equity | $6,158,090 | $5,302,110 | $4,722,841 | $4,690,039 | $4,558,128 |